Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Silence Therapeutics Plc ADR
(NQ:
SLN
)
18.29
+2.09 (+12.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silence Therapeutics Plc ADR
< Previous
1
2
3
4
Next >
Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
January 31, 2024
From
Silence Therapeutics plc
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via
Benzinga
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
December 01, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
November 14, 2023
From
Silence Therapeutics plc
Via
Business Wire
Where Silence Therapeutics Stands With Analysts
August 17, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Silence Therapeutics
June 26, 2023
Via
Benzinga
Silence Therapeutics to Present at Jefferies London Healthcare Conference
November 08, 2023
From
Silence Therapeutics plc
Via
Business Wire
Is This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease Candidate
November 01, 2023
Earlier today, Silence Therapeutics plc (NASDAQ: SLN) announced topline results from the multiple-dose component of the APOLLO phase 1 study of zerlasiran (formerly SLN360) in 36 adults with baseline...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 01, 2023
Via
Benzinga
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease
November 01, 2023
From
Silence Therapeutics plc
Via
Business Wire
The Latest Analyst Ratings for Silence Therapeutics
May 11, 2023
Via
Benzinga
Silence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
September 26, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Participate in September Investor Conferences
September 06, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Reports Second Quarter 2023 Results
August 16, 2023
From
Silence Therapeutics plc
Via
Business Wire
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration
July 11, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Reports First Quarter 2023 Results
May 16, 2023
From
Silence Therapeutics plc
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
May 08, 2023
Via
Benzinga
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration
May 04, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Completes Enrollment in Phase 2 Study of Zerlasiran (SLN360) in Subjects with Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
May 01, 2023
From
Silence Therapeutics plc
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
April 25, 2023
Tuesday's session saw 286 companies set new 52-week lows.
Via
Benzinga
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Investor Conference
April 25, 2023
From
Silence Therapeutics plc
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
April 24, 2023
On Monday, 147 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 21, 2023
During Friday's session, 149 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 17, 2023
Via
Benzinga
Silence Therapeutics Announces Publication in Blood Demonstrating Role for Iron Regulation in Polycythemia Vera
April 04, 2023
From
Silence Therapeutics plc
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
March 29, 2023
On Wednesday, 81 companies hit new 52-week lows.
Via
Benzinga
Silence Therapeutics to Present at Guggenheim’s Genomic Medicines and Rare Disease Days
March 29, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
March 28, 2023
From
Silence Therapeutics plc
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.